ViTrox Hits RM1bil Revenue: Inside Malaysia's Homegrown R&D Machine
The Penang inspection-equipment maker turned RM89mil of R&D into 20 new products and 22.8% of FY2025 revenue — a playbook other Malaysian companies can copy.
ViTrox Corporation Bhd, the Penang-based semiconductor inspection equipment maker, has crossed RM1bil in revenue on a trailing 12-month basis, with 20 new products introduced during FY2025 contributing 22.8% of the year's revenue. The company spent RM89mil on R&D to get there and plans a record US$24.49mil (about RM100mil) budget for 2026. For Malaysian business readers, this is one of the clearest domestic data points that disciplined, sustained R&D spending by a local company can convert into commercial returns at global scale. It also matters because ViTrox sits upstream of the AI boom — every chip that AI demand pulls into production needs inspection. The practical lesson for any Malaysian firm is a copyable one: track what share of your revenue comes from products that are genuinely new, and budget innovation as a percentage of sales rather than as a leftover.
AI Summary
ViTrox Corporation Bhd, the Penang-based semiconductor inspection equipment maker, has crossed RM1bil in revenue on a trailing 12-month basis, with 20 new products introduced during FY2025 contributing 22.8% of the year's revenue. The company spent RM89mil on R&D to get there and plans a record US$24.49mil (about RM100mil) budget for 2026. For Malaysian business readers, this is one of the clearest domestic data points that disciplined, sustained R&D spending by a local company can convert into commercial returns at global scale. It also matters because ViTrox sits upstream of the AI boom — every chip that AI demand pulls into production needs inspection. The practical lesson for any Malaysian firm is a copyable one: track what share of your revenue comes from products that are genuinely new, and budget innovation as a percentage of sales rather than as a leftover.
Key Takeaways
- **New products drove 22.
Sources & References
AIBlog summarises and analyses published information. We do not reproduce full source text. Analysis is editorial and not financial or legal advice.
